Use of thromboelastography PlateletMapping™ to monitor antithrombotic therapy in a patient with Budd‐Chiari syndrome
Katherine James, Elisa Bertoja, James O'Beirne, Susan Mallett – 23 December 2009 – Budd‐Chiari syndrome (BCS) is the end result of a number of disease states resulting in hepatic venous outflow obstruction. We report a Janus kinase 2–homozygous patient with BCS who thrombosed a transjugular intrahepatic portosystemic shunt (TIPS) despite treatment with warfarin (international normalized ratio = 3.0), aspirin, and clopidogrel.